vs

Side-by-side financial comparison of LCNB CORP (LCNB) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $23.9M, roughly 1.1× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -10.3%, a 34.0% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 15.7%).

LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

LCNB vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.1× larger
NPCE
$26.6M
$23.9M
LCNB
Growing faster (revenue YoY)
NPCE
NPCE
+18.8% gap
NPCE
23.9%
5.1%
LCNB
Higher net margin
LCNB
LCNB
34.0% more per $
LCNB
23.7%
-10.3%
NPCE
More free cash flow
LCNB
LCNB
$33.0M more FCF
LCNB
$33.4M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
15.7%
LCNB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LCNB
LCNB
NPCE
NPCE
Revenue
$23.9M
$26.6M
Net Profit
$5.7M
$-2.7M
Gross Margin
77.4%
Operating Margin
29.2%
-6.6%
Net Margin
23.7%
-10.3%
Revenue YoY
5.1%
23.9%
Net Profit YoY
-7.6%
48.0%
EPS (diluted)
$0.40
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCNB
LCNB
NPCE
NPCE
Q4 25
$23.9M
$26.6M
Q3 25
$23.8M
$27.4M
Q2 25
$22.8M
$23.5M
Q1 25
$21.5M
$22.5M
Q4 24
$22.7M
$21.5M
Q3 24
$21.4M
$21.1M
Q2 24
$19.3M
$19.3M
Q1 24
$17.8M
$18.1M
Net Profit
LCNB
LCNB
NPCE
NPCE
Q4 25
$5.7M
$-2.7M
Q3 25
$6.9M
$-3.5M
Q2 25
$5.9M
$-8.7M
Q1 25
$4.6M
$-6.6M
Q4 24
$6.1M
$-5.3M
Q3 24
$4.5M
$-5.5M
Q2 24
$925.0K
$-7.5M
Q1 24
$1.9M
$-8.9M
Gross Margin
LCNB
LCNB
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
LCNB
LCNB
NPCE
NPCE
Q4 25
29.2%
-6.6%
Q3 25
35.6%
-9.5%
Q2 25
31.6%
-29.0%
Q1 25
25.6%
-22.9%
Q4 24
32.9%
-17.0%
Q3 24
24.9%
-20.1%
Q2 24
4.9%
-32.4%
Q1 24
12.5%
-41.6%
Net Margin
LCNB
LCNB
NPCE
NPCE
Q4 25
23.7%
-10.3%
Q3 25
29.1%
-12.8%
Q2 25
26.0%
-36.8%
Q1 25
21.4%
-29.3%
Q4 24
27.0%
-24.5%
Q3 24
21.2%
-25.9%
Q2 24
4.8%
-39.0%
Q1 24
10.7%
-49.2%
EPS (diluted)
LCNB
LCNB
NPCE
NPCE
Q4 25
$0.40
$-0.08
Q3 25
$0.49
$-0.11
Q2 25
$0.41
$-0.26
Q1 25
$0.33
$-0.21
Q4 24
$0.44
$-0.16
Q3 24
$0.31
$-0.19
Q2 24
$0.07
$-0.26
Q1 24
$0.15
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCNB
LCNB
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$21.6M
$61.1M
Total DebtLower is stronger
$104.4M
Stockholders' EquityBook value
$273.9M
$19.0M
Total Assets
$2.2B
$105.6M
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCNB
LCNB
NPCE
NPCE
Q4 25
$21.6M
$61.1M
Q3 25
$35.9M
$60.0M
Q2 25
$49.8M
$62.1M
Q1 25
$37.7M
$66.3M
Q4 24
$35.7M
$52.8M
Q3 24
$39.4M
$56.8M
Q2 24
$34.9M
$55.5M
Q1 24
$33.0M
$58.9M
Total Debt
LCNB
LCNB
NPCE
NPCE
Q4 25
$104.4M
Q3 25
$104.7M
Q2 25
$105.0M
Q1 25
$104.6M
Q4 24
$155.2M
Q3 24
$155.7M
Q2 24
$162.2M
Q1 24
$162.6M
Stockholders' Equity
LCNB
LCNB
NPCE
NPCE
Q4 25
$273.9M
$19.0M
Q3 25
$269.9M
$18.5M
Q2 25
$263.5M
$19.4M
Q1 25
$258.7M
$24.3M
Q4 24
$253.0M
$8.0M
Q3 24
$253.2M
$9.8M
Q2 24
$245.2M
$9.9M
Q1 24
$233.7M
$14.3M
Total Assets
LCNB
LCNB
NPCE
NPCE
Q4 25
$2.2B
$105.6M
Q3 25
$2.2B
$107.3M
Q2 25
$2.3B
$106.1M
Q1 25
$2.3B
$110.2M
Q4 24
$2.3B
$94.6M
Q3 24
$2.3B
$96.3M
Q2 24
$2.4B
$94.4M
Q1 24
$2.3B
$98.9M
Debt / Equity
LCNB
LCNB
NPCE
NPCE
Q4 25
0.38×
Q3 25
0.39×
Q2 25
0.40×
Q1 25
0.40×
Q4 24
0.61×
Q3 24
0.61×
Q2 24
0.66×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCNB
LCNB
NPCE
NPCE
Operating Cash FlowLast quarter
$34.4M
$506.0K
Free Cash FlowOCF − Capex
$33.4M
$409.0K
FCF MarginFCF / Revenue
140.2%
1.5%
Capex IntensityCapex / Revenue
4.0%
0.4%
Cash ConversionOCF / Net Profit
6.08×
TTM Free Cash FlowTrailing 4 quarters
$54.5M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCNB
LCNB
NPCE
NPCE
Q4 25
$34.4M
$506.0K
Q3 25
$14.0M
$-1.9M
Q2 25
$5.5M
$-2.1M
Q1 25
$2.2M
$-7.5M
Q4 24
$93.2M
$-4.8M
Q3 24
$11.9M
$-1.7M
Q2 24
$54.9M
$-3.9M
Q1 24
$-11.9M
$-7.5M
Free Cash Flow
LCNB
LCNB
NPCE
NPCE
Q4 25
$33.4M
$409.0K
Q3 25
$13.7M
$-2.0M
Q2 25
$5.2M
$-2.3M
Q1 25
$2.1M
$-7.5M
Q4 24
$89.4M
$-4.8M
Q3 24
$10.5M
$-1.8M
Q2 24
$53.8M
$-4.0M
Q1 24
$-12.8M
$-7.6M
FCF Margin
LCNB
LCNB
NPCE
NPCE
Q4 25
140.2%
1.5%
Q3 25
57.4%
-7.2%
Q2 25
23.0%
-9.6%
Q1 25
10.0%
-33.4%
Q4 24
394.0%
-22.5%
Q3 24
49.0%
-8.7%
Q2 24
278.6%
-20.6%
Q1 24
-71.8%
-42.1%
Capex Intensity
LCNB
LCNB
NPCE
NPCE
Q4 25
4.0%
0.4%
Q3 25
1.3%
0.1%
Q2 25
1.0%
0.7%
Q1 25
0.3%
0.2%
Q4 24
16.7%
0.2%
Q3 24
6.7%
0.5%
Q2 24
5.9%
0.3%
Q1 24
4.8%
0.6%
Cash Conversion
LCNB
LCNB
NPCE
NPCE
Q4 25
6.08×
Q3 25
2.02×
Q2 25
0.92×
Q1 25
0.48×
Q4 24
15.23×
Q3 24
2.63×
Q2 24
59.35×
Q1 24
-6.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons